A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy

Condition:   Head and Neck Cancer
Interventions:   Drug: Pembrolizumab;   Drug: epacadostat
Sponsor:   University of Chicago
Not yet recruiting - verified August 2017

http://ift.tt/2fasYOS